Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Prothena Corporation plc, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Prothena Corporation plc May 16, 202399.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 12, 2026 | Aktis Oncology Inc. | Derivative conversion | +4,859,370 | — | — |
| Jan 12, 2026 | Aktis Oncology Inc. | Open-market purchase | +812,455 | $18.00 | $14,624,190 |
| Jan 12, 2026 | Aktis Oncology Inc. | Derivative conversion | +134,842 | — | — |
| Jan 12, 2026 | Aktis Oncology Inc. | Open-market purchase | +22,545 | $18.00 | $405,810 |
Questions about Helen Susan Kim
What boards is Helen Susan Kim on?
Helen Susan Kim sits on the boards of Aktis Oncology Inc. and Prothena Corporation plc.
How long has Helen Susan Kim served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.